openPR Logo
Press release

Plaintiff in Dallas Federal Lawsuit says U.S. Gun Control Laws Unconstitutional

11-15-2006 05:19 PM CET | Politics, Law & Society

Press release from: Second Amendment Foundation

DALLAS – A United States citizen who now lives in Great Britain has joined with the country’s leading gun owner rights organization in a federal lawsuit that says nonresident citizens are unfairly being targeted by existing laws that restrict gun ownership to those who live in the U.S.

Attorneys William B. Mateja, a principal in the Dallas and Washington, D.C., offices of Fish & Richardson P.C., and Alan Gura of Alexandria, Va.’s Gura & Possessky, PLLC, filed the federal claim today on behalf of London, England, resident Maxwell Hodgkins and the Bellevue, Wash.-based Second Amendment Foundation.

Mr. Hodgkins, a 31-year-old real estate broker, is asking for a legal injunction that would prohibit federal officials from enforcing several “vague and ambiguous” gun control statutes. A Dallas native, Mr. Hodgkins is an avid gun collector and sportsman who legally owns and stores firearms in the U.S. and holds related permits for weapons possession and concealment.

Mr. Mateja previously served in the current Bush Administration as Senior Counsel to the U.S. Deputy Attorney General. Among other duties, he oversaw the Justice Department's violent crime efforts, including the Bureau of Alcohol, Tobacco and Firearms, and President Bush's Project Safe Neighborhood. Prior to that, he served as lead counsel in the notable Second Amendment case U.S. v. Timothy Joe Emerson.

The statutes in question ban the receipt, sale and purchase of firearms by U.S. citizens who claim legal residency outside the U.S. Expatriates cannot buy guns, and while they can receive guns for “lawful sporting purposes,” they cannot do so for lawful self defense while visiting the U.S. The suit claims that these laws violate the Second and Fifth Amendments to the U.S. Constitution. Although Mr. Hodgkins has not been arrested or prosecuted, his attorneys say he could face federal charges should he attempt to access his guns in the U.S.

“These laws serve no useful purpose,” says Mr. Gura. “If Mr. Hodgkins may safely have a gun for target practice or hunting, he can certainly have a gun for other lawful purposes.”

Alan Gottlieb, founder and vice president of the Second Amendment Foundation, says: “The firearms rights of American citizens do not become null and void simply because an individual lives in another country. There is no public safety rationale for laws or regulations that prohibit law-abiding citizens from exercising their rights while they are on American soil. We cannot allow a legal environment to exist where the exercise of a civil right by an American citizen anywhere in the United States is conditional to that person’s country of residence.”

For more information contact:
Bruce Vincent
Androvett Legal Media
800-559-4534
bruce@legalpr.com

The Second Amendment Foundation provides education, research, publishing and legal action focusing on the constitutional right to privately own and possess firearms, and the consequences of gun control. The organization has more 600,000 members and supporters nationwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plaintiff in Dallas Federal Lawsuit says U.S. Gun Control Laws Unconstitutional here

News-ID: 12865 • Views:

More Releases for Hodgkins

Non-Hodgkins Lymphoma Treatment Market: An Investor's Guide to Understand Market …
The Non-Hodgkins Lymphoma Treatment market report presents the global Non-Hodgkins Lymphoma Treatment sales and revenue by companies, regions, type and application and forecast to 2028. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. Non-Hodgkins lymphoma (NHL) is a type of cancer, occurring due to abnormal functioning of leukocytes and B
Hodgkins lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023
"The Report Hodgkins lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​DelveInsights Hodgkins lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Hodgkins lymphoma (HL) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and
Hodgkins Lymphoma Market 2024: Opportunity Analysis and Forecasts
"The Latest Research Report OpportunityAnalyzer: Hodgkins Lymphoma (HL) - Opportunity Analysis and Forecasts to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Hodgkins Lymphoma Market Hodgkins lymphoma (HL), or Hodgkins disease, is a malignancy which involves the lymph nodes and the lymphatic system. HL is a relatively rare type of cancer, accounting for 12% of all lymphomas and 0.6% of all
B-Cell Non-Hodgkins Lymphoma Market 2024: Opportunity Analysis and Forecasts
"The Latest Research Report OpportunityAnalyzer: B-Cell Non-Hodgkins Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About B-Cell Non-Hodgkins Lymphoma Market Non-Hodgkins lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone
Global Forecast Of Epidemiology Of Non-Hodgkins Lymphoma (NHL) Till 2023
Researchmoz added Most up-to-date research on " Global Forecast Of Epidemiology Of Non-Hodgkins Lymphoma (NHL) Till 2023" to its huge collection of research reports. DelveInsights Non-Hodgkins Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Non-Hodgkins Lymphoma (NHL) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the
New Study Reveals Non-Hodgkins Lymphoma (NHL) Therapeutics Market Analysis And F …
Researchmoz added Most up-to-date research on "Non-Hodgkins Lymphoma (NHL) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020" to its huge collection of research reports. Lymphoma is one of the most hazardous and life threatening type of cancer, related to lymphocytes, an important type of white blood cells. Non-Hodgkin’s lymphomas (NHL) is a distinct group of blood cancer, which includes large variety of lymphomas, excluding